168 related articles for article (PubMed ID: 1402399)
1. Effect of cutaneous permeability barrier disruption on HMG-CoA reductase, LDL receptor, and apolipoprotein E mRNA levels in the epidermis of hairless mice.
Jackson SM; Wood LC; Lauer S; Taylor JM; Cooper AD; Elias PM; Feingold KR
J Lipid Res; 1992 Sep; 33(9):1307-14. PubMed ID: 1402399
[TBL] [Abstract][Full Text] [Related]
2. Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis.
Harris IR; Farrell AM; Grunfeld C; Holleran WM; Elias PM; Feingold KR
J Invest Dermatol; 1997 Dec; 109(6):783-7. PubMed ID: 9406821
[TBL] [Abstract][Full Text] [Related]
3. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements.
Proksch E; Elias PM; Feingold KR
J Clin Invest; 1990 Mar; 85(3):874-82. PubMed ID: 2312730
[TBL] [Abstract][Full Text] [Related]
4. Localization and regulation of epidermal 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity by barrier requirements.
Proksch E; Elias PM; Feingold KR
Biochim Biophys Acta; 1991 Apr; 1083(1):71-9. PubMed ID: 2031940
[TBL] [Abstract][Full Text] [Related]
5. Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters.
Feingold KR; Hardardottir I; Memon R; Krul EJ; Moser AH; Taylor JM; Grunfeld C
J Lipid Res; 1993 Dec; 34(12):2147-58. PubMed ID: 8301233
[TBL] [Abstract][Full Text] [Related]
6. Epidermal HMG CoA reductase activity in essential fatty acid deficiency: barrier requirements rather than eicosanoid generation regulate cholesterol synthesis.
Proksch E; Feingold KR; Elias PM
J Invest Dermatol; 1992 Aug; 99(2):216-20. PubMed ID: 1629633
[TBL] [Abstract][Full Text] [Related]
7. Parallel regulation of sterol regulatory element binding protein-2 and the enzymes of cholesterol and fatty acid synthesis but not ceramide synthesis in cultured human keratinocytes and murine epidermis.
Harris IR; Farrell AM; Holleran WM; Jackson S; Grunfeld C; Elias PM; Feingold KR
J Lipid Res; 1998 Feb; 39(2):412-22. PubMed ID: 9508001
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors.
Bisgaier CL; Essenburg AD; Auerbach BJ; Pape ME; Sekerke CS; Gee A; Wölle S; Newton RS
J Lipid Res; 1997 Dec; 38(12):2502-15. PubMed ID: 9458274
[TBL] [Abstract][Full Text] [Related]
9. Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells.
Morikawa S; Umetani M; Nakagawa S; Yamazaki H; Suganami H; Inoue K; Kitahara M; Hamakubo T; Kodama T; Saito Y
J Atheroscler Thromb; 2000; 7(3):138-44. PubMed ID: 11480454
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase, synthase, and low density lipoprotein receptor genes.
Cuthbert JA; Lipsky PE
J Lipid Res; 1992 Aug; 33(8):1157-63. PubMed ID: 1358996
[TBL] [Abstract][Full Text] [Related]
11. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
Yu L; Qiu S; Genest J
Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
[TBL] [Abstract][Full Text] [Related]
12. Barrier function regulates epidermal lipid and DNA synthesis.
Proksch E; Holleran WM; Menon GK; Elias PM; Feingold KR
Br J Dermatol; 1993 May; 128(5):473-82. PubMed ID: 8504036
[TBL] [Abstract][Full Text] [Related]
13. Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver.
Powell EE; Kroon PA
J Clin Invest; 1994 May; 93(5):2168-74. PubMed ID: 8182149
[TBL] [Abstract][Full Text] [Related]
14. Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase.
Ness GC; Zhao Z; Keller RK
Arch Biochem Biophys; 1994 Jun; 311(2):277-85. PubMed ID: 7911291
[TBL] [Abstract][Full Text] [Related]
15. Short-term effects of ACTH on the low-density lipoprotein receptor mRNA level in rat and hamster adrenals.
Lehoux JG; Lefebvre A
J Mol Endocrinol; 1991 Jun; 6(3):223-30. PubMed ID: 1652971
[TBL] [Abstract][Full Text] [Related]
16. Discordant regulation of proteins of cholesterol metabolism during the acute phase response.
Feingold KR; Pollock AS; Moser AH; Shigenaga JK; Grunfeld C
J Lipid Res; 1995 Jul; 36(7):1474-82. PubMed ID: 7595071
[TBL] [Abstract][Full Text] [Related]
17. Diabetes increases hepatic hydroxymethyl glutaryl coenzyme A reductase protein and mRNA levels in the small intestine.
Feingold KR; Wilson DE; Wood LC; Kwong LK; Moser AH; Grunfeld C
Metabolism; 1994 Apr; 43(4):450-4. PubMed ID: 8159102
[TBL] [Abstract][Full Text] [Related]
18. Effect of dietary cholesterol on low density lipoprotein-receptor, 3-hydroxy-3-methylglutaryl-CoA reductase, and low density lipoprotein receptor-related protein mRNA expression in healthy humans.
Boucher P; de Lorgeril M; Salen P; Crozier P; Delaye J; Vallon JJ; Geyssant A; Dante R
Lipids; 1998 Dec; 33(12):1177-86. PubMed ID: 9930403
[TBL] [Abstract][Full Text] [Related]
19. The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Berkhout TA; Simon HM; Patel DD; Bentzen C; Niesor E; Jackson B; Suckling KE
J Biol Chem; 1996 Jun; 271(24):14376-82. PubMed ID: 8662919
[TBL] [Abstract][Full Text] [Related]
20. Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels are coordinately reduced in human renal cell carcinoma.
Rudling M; Collins VP
Biochim Biophys Acta; 1996 Jan; 1299(1):75-9. PubMed ID: 8555255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
